王建飞 博士 南京艾美斐生物医药科技有限公司 首席科学官
比较医学高级医师,国际AAALAC认可委员会常务理事,中科院上海生命科学研究院教授(兼),上海科学院特聘教授。加拿大卡尔加里大学分子细胞学博士学位,在美国哈佛大学医学院从事博士后研究。 曾任美国宾夕法尼亚大学比较医学住院医师4年,并获执医资质,任加拿大艾尔伯塔大学医学院外科系教授。 曾担任GSK中国研发中心整合生物技术科研部负责人,建立了完整的临床前研发平台,为公司的数十个项目提供靶点验证、先导化合物优化、药效学和药代动力学研究提供科学及技术支持,获得GSK中国研发中心包括金奖在内的多次表彰,GSK全球整合生物平台科研部领导之一, 并成功地推动多个新药研发项目完成临床申报,进入临床试验,被评为高级GSK研究员(Senior GSK Fellow,公司科研最高级别学者)。在转化医学研究方面拥有超过28年的经验,在世界著名的国际期刊上发表了70多篇论文,10多篇书刊章节,获多项专利。
Dr. Jianfei Wang
Chief Scientific Officer (CSO), Member of the Board
Senior Physician in Comparative Medicine
Professor of CAS Shanghai Institute of Biological Sciences (adjunct)
Honorary Head and Professor, Institute of Translational Medicine, Shanghai Academy of Sciences
Distinguished professor of Yunnan Agricultural University
Dr. Wang received a Ph.D. in Molecular Cell Biology from the University of Calgary, Canada and completed his residency in Comparative Medicine at the University of Pennsylvania, USA. He then pursued his postdoctoral research at Harvard Medical School. He was later appointed as a faculty member in the Department of Surgery at the Faculty of Medicine at the University of Alberta, Canada, before returning to China.
Dr. Wang is a seasoned executive with solid knowledge of both small and large molecule drugs and extensive experience in program insight for shaping R&D strategy. He has over 28 years of translational medicine research and team management experience in multinational pharmaceutical companies. At GSK R&D China, Dr. Wang established an integrated preclinical platform that provided support for target identification, validation, lead compound optimization, DMPK studies, discovery histopathology, safety assessment, and blood-brain barrier penetration for many projects that proceeded to candidate selections and clinical trials. Due to his distinguished contributions, Dr. Wang received many awards from GSK R&D China. He also served as a core member of the GSK global translational medicine leadership team and was elected as a Senior GSK Fellow, the highest level of scientific research scholar.
Dr. Wang’s contributions to translational medicine & drug discovery are recognized by being granted numerous distinguished awards, including an outstanding scientist by numerous national and international organizations. He has published more than 70 papers in prestigious international journals and owns multiple patents.